Severens J, Kleijnen J. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2015;19(58):l-228, v-vi. doi: 10.3310/htal9580.
↩
72. Llau J V, Acosta FJ, Escolar G, Fernández-Mondéjar E, Guasch E, Marco P, Paniagua P,
Paramo JA, Quintana M, Torrabadella P. Multidisciplinary consensus document on the management of massive haemorrhage (HEMOMAS document). Med intensiva.
2015;39(8):483-504. doi: 10.1016/j .medin.2015.05.002.
↩
73. Queensland clinical guidelines. Primary postpartum haemorrage.
↩
↩
74. Kozek-Langenecker SA. Fluids and coagulation. Curr Opin Crit Care. 2015;21(4):285-91. doi: 10.1097/MCC.0000000000000219.
↩
↩
72. Llau J V, Acosta FJ, Escolar G, Fernández-Mondéjar E, Guasch E, Marco P, Paniagua P,
Paramo JA, Quintana M, Torrabadella P. Multidisciplinary consensus document on the management of massive haemorrhage (HEMOMAS document). Med intensiva.
2015;39(8):483-504. doi: 10.1016/j .medin.2015.05.002.
↩
73. Queensland clinical guidelines. Primary postpartum haemorrage.
↩
↩
74. Kozek-Langenecker SA. Fluids and coagulation. Curr Opin Crit Care. 2015;21(4):285-91. doi: 10.1097/MCC.0000000000000219.
↩
75. Sommer N, Schrüriger B, Candinas D, Haltmeier T. Massive transfusion protocols in nontrauma patients: A systematic review and meta-analysis. J Trauma Acute Care Surg.
2019;86(3):493-504. doi:10.1097/TA.0000000000002101.
↩
76. Tanaka H, Matsunaga S, Yamashita T, Okutomi T, Sakurai A, Sekizawa A, Hasegawa J,
Terui K, Miyake Y, Murotsuki J, Ikeda T. A systematic review of massive transfusion protocol in obstetrics. Taiwan J Obstet Gynecol. 2017;56(6):715-8. doi:10.1016/j.tjog.2017.10.001.
↩
77. Bhangu A, Nepogodiev D, Doughty H, Bowley DM. Meta-analysis of plasma to red blood cell ratios and mortality in massive blood transfusions for trauma. Injury. 2013;44(12): 1693-
9. doi:10.1016/j.injury.2012.07.193.
↩
78. Snegovskikh D, Souza D, Walton Z, Dai F, Rachler R, Garay A, Snegovskikh VV, Braveman
FR, Norwitz ER. Point-of-care viscoelastic testing improves the outcome of pregnancies complicated by severe postpartum hemorrhage. J Clin Anesth. 2018;44:50-6. doi: 10.1016/j .j clinane.2017.10.003.
↩
79. Butwick AJ, Goodnough LT. Transfusion and coagulation management in major obstetric hemorrhage. Curr Opin Anaesthesiol. 2015;28(3):275-84. doi:
10.1097/ACO.0000000000000180.
↩
80. Collis RE, Collins PW. Haemostatic management of obstetric haemorrhage. Anaesthesia.
2015;70 Suppl 1:78-86, e27-8. doi:10.1111/anae.l2913.
↩
81. Postpartum Haemorrhage, Prevention and Management (Green-top Guideline No. 52).
December 2016.
↩
82. Reddy S, Weinberg L, Young P. Crystalloid fluid therapy. Crit Care. 2016;20(20):59. doi:10.1186/sl3054-016-1217-5.
↩
83. National Clinical Guideline Centre (UK). Intravenous Fluid Therapy: Intravenous Fluid
Therapy in Adults in Hospital. R Coll Physicians. 2013;
↩
84. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CAA, De Robertis E, Filipescu
DC, Fries D, Gorlinger K, Haas T, Imberger G, Jacob M, Lance M, Llau J, Mallett S, Meier
J, Rahe-Meyer N, Samama CM, Smith A, Solomon C, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J
Anaesthesiol. 2013;30(6):270-382. doi:10.1097/EJA.0b013e32835f4d5b.
↩
↩
85. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Filipescu
D, Hunt BJ, Komadina R, Nardi G, Neugebauer EAM, Ozier Y, Riddez L, Schultz A,
Vincent J-L, Spahn DR. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20(l):100. doi:10.1186/sl3054-016-1265-x.
↩
86.
1. American Society of Anesthesiologists Task Force on Perioperative Blood
Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative
Blood Management. Anesthesiology. 2015;122(2):241-75.
↩
↩
87. Blood Transfusion in Obstetrics Royal College of Obstetricians and Gynaecologists/. RCOG
Green-top Guidel No 47. 2015;23 p.
↩
↩
88. Hovaguimian F, Myles PS. Restrictive versus Liberal Transfusion Strategy in the
Perioperative and Acute Care Settings: A Context-specific Systematic Review and
Meta¬analysis of Randomized Controlled Trials. Anesthesiology. 2016;125(l):46-61. doi:
10.1097/ALN.OOOOOOOOOOOO 1162.
↩
89. Goucher H, Wong CA, Patel SK, Toledo P. Cell Salvage in Obstetrics. Anesth Analg. 2015;
121 (2):465-8. doi: 10.1213/ANE.0000000000000786.
↩
↩↩
90. Доброхотова ЮЭ, Джобава ЭМ, Данелян СЖ, Залесская СА. Послеродовые кровотечения. Обоснование оптимальной гемостатической фармакотерапии.
Российский вестник акушера-гинеколога. 2013;(6):99-102.
↩
91. Bolliger D, Mauermann Е, Tanaka КА. Thresholds for Perioperative Administration of
Hemostatic Blood Components and Coagulation Factor Concentrates: An Unmet Medical
Need. J Cardiothorac Vase Anesth. 2015;29(3):768-76. doi:10.1053/j.jvca.2015.02.023.
↩
92. Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K,
Bødker B, Magnusdottir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D,
Gyte G. Use of recombinant activated factor VII in primary postpartum hemorrhage: the
Northern European registry 2000-2004. Obstet Gynecol. 2007;110(6): 1270-8. doi:10.1097/01.AOG.0000288515.48066.99.
↩
93. Huber A W, Raio L, Alberio L, Ghezzi F, Surbek D V. Recombinant human factor Vila prevents hysterectomy in severe postpartum hemorrhage: single center study. J Perinat Med.
201 l;40(l):43-9. doi: 10.1515/JPM.2011.109.
↩
94. Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron
PA, Australian and New Zealand Haemostasis Registry. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis
Registry. Anesth Analg. 2009; 109(6): 1908-15. doi:10.1213/ANE.0b013e3181c039e6.
↩
95. Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E,
Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P,
Bouvet S, Fabbro-Peray P, Gris J-C. Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. J Thromb Haemost. 2015;13(4):520-9. doi:10.1111/jth.12844.
↩
96. Franchini M, Manzato F, Salvagno GL, Lippi G. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review. Blood Coagul Fibrinolysis. 2007; 18(7):589-93. doi:10.1097/MBC.0b013e32822d2a3c.
↩
97. Brenner B, Wiis J. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency. Hematology. 2007;12(l):55-62. doi:
10.1080/10245330601111573.
↩
98. Shah NM, Chong SE, Yusoff SM, Mazlan MZ, Johan KB, Azman N, Lim JA, Mohamad SM,
Noordin SS, Ghaffar Z4, Hassan MH, Zabidi MA, Rahim NAA. Recombinant activated factor VII (rFVIIa) in refractory haemorrhage for non-haemophiliacs: an eleven- year single- centre experience. BMCHematol. 2018;18:34. doi:10.1186/sl2878-018-0126- z.
↩
99. Liumbruno GM, Liumbruno C, Rafanelli D. Intraoperative cell salvage in obstetrics: is it a real therapeutic option? Transfusion. 2011;51(10):2244-56. doi:10.1111/j.l537-
2995.2011.03116.x.
↩
↩
100.
Greenawalt JA, Zernell D. Autologous Blood Transfusion for Postpartum
Hemorrhage. MCN Am J Matem Child Nurs. 42(5):269-75. doi:10.1097/NMC.0000000000000359.
↩
↩
101.
Lim G, Melnyk V, Facco FL, Waters JH, Smith KJ. Cost-effectiveness Analysis of
Intraoperative Cell Salvage for Obstetric Hemorrhage. Anesthesiology. 2018;128(2):328-37. doi:10.1097/ALN.0000000000001981.
↩
102.
Кровесберегающие технологии в акушерской практике. Клинические рекомендации (протокол лечения). Письмо Министерства здравоохранения РФ от 27 мая 2014 г. N 15-4/10/2-379839.
↩
103.
Waters JH, Biscotti С, Potter PS, Phillipson E. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology. 2000;92(6):1531-6.
↩
104.
Working Party:, Association of Anaesthetists of Great Britain & Ireland, Obstetric
Anaesthetists’ Association, Regional Anaesthesia UK. Regional anaesthesia and patients with abnormalities of coagulation: the Association of Anaesthetists of Great Britain & Ireland The
Obstetric Anaesthetists’ Association Regional Anaesthesia UK. Anaesthesia.
2013;68(9):966-72. doi: 10.111 1/anae.12359.
↩
105.
Horlocker TT, Vandermeuelen E, Kopp SL, Gogarten W, Leffert LR, Benzon HT.
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy:
American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines
(Fourth Edition). Reg Anesth Pain Med. 2018;43(3):263-309. doi:
10.1097/AAP.0000000000000763.
↩
106.
El Khouly NI. Comparison of intravenous ferrous sucrose and oral ferrous sulphate in treatment of postpartum iron deficiency anemia. J Matem Fetal Neonatal Med.
2017;30(8):967-71. doi:10.1080/14767058.2016.1192602
↩
1 2 3 4 5 6 7 8